What is triple-negative breast cancer and how is it identified? How can triple-negative breast cancers escape the immune system? And how can determining whether circulating tumor DNA in blood samples be used to predict metastatic breast cancer or treatment resistance in patients with aggressive disease?
BCRF investigator since 2007, Dr. Hope Rugo answers these questions and many more on the latest episode of Investigating Breast Cancer.
Improving Treatments for Invasive Lobular Carcinoma with Dr. Adrian Lee
Improving Breast Cancer Radiation Treatments with Dr. Rachel Jimenez
The Effects of a High-Fiber Diet in Early-Stage Breast Cancer with Dr. Laura Esserman
BCRF 2023 New York City Symposium
Investigating Novel Biomarkers for Personalized Treatments with Dr. Roisin Connolly
Reflecting on Thirty Years of Progress with Dr. Larry Norton
The Progress and Future of Breast Cancer Vaccines with Dr. Nora Disis
The Future of Breast Cancer Risk Prediction with Dr. Regina Barzilay
Lowering Barriers to Breast Cancer Genetic Testing with Dr. Susan Domchek
Studying Breast Cancer Risk in Asian American Communities with Dr. Scarlett Gomez
Bridging the Gap Between the Lab and Patient Care with Dr. Ian Krop
Understanding and Targeting Triple-Negative Breast Cancer with Dr. Jill Bargonetti
Exploring Social Determinants of Health in Breast Cancer Care with Dr. Sonya Reid
BCRF Investigators Discuss the Latest in Breast Cancer Research at 2022 Symposium
Finding and Targeting “Sleeping” Cancer Cells with Dr. Angela DeMichele
Investigating What Drives Recurrence and Metastasis with Dr. Christina Curtis
The Impact of Chemotherapy on Accelerated Aging in Elderly Patients with Dr. Hyman Muss
Improving Breast Cancer Care and Narrowing the Health Disparities Gap with Dr. Dawn Hershman
The Urgent Need for Triple-Negative Breast Cancer Breakthroughs with Dr. Elisa Port
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
2 Peas in A Pod
LMU An introduction to Bohmian Mechanics